ChoA Pharmaceutical Co Ltd banner
C

ChoA Pharmaceutical Co Ltd
KOSDAQ:034940

Watchlist Manager
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
Watchlist
Price: 1 002 KRW -3.28% Market Closed
Market Cap: ₩31B

ChoA Pharmaceutical Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ChoA Pharmaceutical Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
C
ChoA Pharmaceutical Co Ltd
KOSDAQ:034940
Research & Development
-₩1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Research & Development
-₩197B
CAGR 3-Years
-19%
CAGR 5-Years
-10%
CAGR 10-Years
-19%
SK Biopharmaceuticals Co Ltd
KRX:326030
Research & Development
-₩162.2B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Research & Development
-₩189.1B
CAGR 3-Years
-9%
CAGR 5-Years
4%
CAGR 10-Years
-1%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Research & Development
-₩8.7B
CAGR 3-Years
-8%
CAGR 5-Years
17%
CAGR 10-Years
-9%
C
Caregen Co Ltd
KOSDAQ:214370
Research & Development
-₩5.7B
CAGR 3-Years
3%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
No Stocks Found

ChoA Pharmaceutical Co Ltd
Glance View

Market Cap
31B KRW
Industry
Pharmaceuticals

ChoA Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicine and health supplement food. The company is headquartered in Seoul, Seoul. The Company’s products are mainly for treatment of indigestion, gastric ulcer, duodenal ulcer, gastritis, gastric hyperacidity, intestinal disorder, constipation, diarrhea, stomachache, calcium deficiency, fatigue, iron deficiency anemia, neurasthenia, hypertension, hyperlipidemia, circulatory disorder, medicine poisoning, hepatic disease, allergic rhinitis, cough, cold, rheumatoid arthritis and others. The company also provides nutrition products, health drinks, mixed drinks, beverages for children, cosmetics and others.

Intrinsic Value
1 451.78 KRW
Undervaluation 31%
Intrinsic Value
Price
C

See Also

What is ChoA Pharmaceutical Co Ltd's Research & Development?
Research & Development
-1.2B KRW

Based on the financial report for Sep 30, 2025, ChoA Pharmaceutical Co Ltd's Research & Development amounts to -1.2B KRW.

What is ChoA Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 1Y
-196%

Over the last year, the Research & Development growth was -196%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett